⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8003111 | 0.82 | CA2 (0.68) | — | |
| SCHEMBL6820402 | 0.79 | HDAC7 (0.50) | — | |
| SCHEMBL247701 | 0.77 | CA2 (0.44) | — | |
| SCHEMBL633191 | 0.77 | CA2 (0.44) | — | |
| Ethylene SCHEMBL1732619 | 0.76 | CA2 (0.40) | — | |
| SCHEMBL513726 | 0.76 | — | — | |
| SCHEMBL184812 | 0.74 | — | — | |
| SCHEMBL284647 | 0.74 | ALDH1A1 (0.50) | — | |
| SCHEMBL416753 | 0.74 | CA2 (0.43) | — | |
| SCHEMBL247061 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2044085-B1 | PENEM PRODRUGS | PFIZER PROD INC (US) | 2010-12-29 | — | — | EP | claimed |
| US-7795243-B2 | Penem prodrugs | PFIZER, INC. (US) | 2010-09-14 | — | — | US | claimed |
| EP-2044085-A2 | PENEM PRODRUGS | Pfizer Products Incorporated (US) | 2009-04-08 | — | — | EP | claimed |
| US-20080009474-A1 | PENEM PRODRUGS | PFIZER INC | 2008-01-10 | — | — | US | claimed |
| WO-2008001212-A2 | PENEM PRODRUGS | PFIZER PRODUCTS INC. (US) | 2008-01-03 | — | — | WO | claimed |
| WO-2004046153-A1 | PRODRUG ESTERS OF CEFTRIAXONE | RANBAXY LABORATORIES LIMITED (IN) | 2004-06-03 | — | — | WO | claimed |
| US-4699979-A | 7-amino-3-propenylcephalosporanic acid and esters thereof | BRISTOL-MEYERS COMPANY (US) | 1987-10-13 | — | — | US | claimed |
| US-4463002-A | Syn-isomers of 7-substituted-3-cephem-4-carboxylic acid esters | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-07-31 | — | — | US | claimed |
| US-4406887-A | PENICILLINS AND CEPHALOSPORIN MIXTURES | BRISTOL-MYERS COMPANY (US) | 1983-09-27 | — | — | US | claimed |
| US-4380512-A | INHIBITORS OF 3-LACTAMASES | BRISTOL-MYERS COMPANY (US) | 1983-04-19 | — | — | US | claimed |
| EP-0065745-A2 | Syn-isomers of 7-substituted-3-cephem-4-carboxylic acid esters, and a process for production thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1982-12-01 | — | — | EP | claimed |
| JP-57193489-A | — | — | None | — | — | JP | disclosed |
| US-20220194964-A1 | SOLID FORMS OF AN ORALLY-DELIVERED BETA-LACTAMASE INHIBITOR AND USES THEREOF | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2022-06-23 | — | — | US | disclosed |
| US-20220194964-A1 | SOLID FORMS OF AN ORALLY-DELIVERED BETA-LACTAMASE INHIBITOR AND USES THEREOF | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2022-06-23 | — | — | US | disclosed |
| US-20220125812-A1 | COMBINATION COMPOSITIONS COMPRISING A BETA-LACTAMASE INHIBITOR AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-04-28 | — | — | US | disclosed |
| JP-S57193489-A | SYN-ISOMER OF 7-SUBSTITUTED-3-CEPHEM-4-CARBOXYLIC ACID ESTER AND ITS PREPARATION | FUJISAWA PHARMACEUT CO LTD | 1982-11-27 | — | — | JP | disclosed |
| US-4340539-A | ENZYME INHIBITORS OF B-LACTAMASES | BRISTOL-MYERS COMPANY (US) | 1982-07-20 | — | — | US | disclosed |
| US-4231928-A | 6-(7-HYDROXY-4-OXO-4H-PYRIMIDO(1,2-B)PYRIDAZIN-3-YL-CARBOXAMIDO) SUBSTITUTED PENICILLINS | BRISTOL-MYERS COMPANY (US) | 1980-11-04 | — | — | US | disclosed |
| US-4206116-A | ANTIBIOTICS, BACTERICIDES, PSEUDOMONAS | BRISTOL-MYERS COMPANY (US) | 1980-06-03 | — | — | US | disclosed |
| US-4081441-A | PENICILLANIC ACIDS | BRISTOL-MYERS COMPANY (US) | 1978-03-28 | — | — | US | disclosed |